These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 33170349)

  • 1. Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study.
    Chatzantonis G; Bietenbeck M; Elsanhoury A; Tschöpe C; Pieske B; Tauscher G; Vietheer J; Shomanova Z; Mahrholdt H; Rolf A; Kelle S; Yilmaz A
    Clin Res Cardiol; 2021 Apr; 110(4):555-568. PubMed ID: 33170349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of the novel CMR parameter "myocardial transit-time" (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy.
    Chatzantonis G; Bietenbeck M; Florian A; Meier C; Stalling P; Korthals D; Reinecke H; Yilmaz A
    Clin Res Cardiol; 2021 Jan; 110(1):136-145. PubMed ID: 32372287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of Cardiac Involvement in Amyloid A Amyloidosis by Cardiovascular Magnetic Resonance Imaging.
    Chamling B; Drakos S; Bietenbeck M; Klingel K; Meier C; Yilmaz A
    Front Cardiovasc Med; 2021; 8():757642. PubMed ID: 34646875
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-invasive diagnosis of transthyretin cardiac amyloidosis utilizing typical late gadolinium enhancement pattern on cardiac magnetic resonance and light chains.
    Slivnick JA; Alvi N; Singulane CC; Scheetz S; Goyal A; Patel H; Sarswat N; Addetia K; Fernandes F; Vieira MLC; Cafezeiro CRF; Carvalhal SF; Simonetti OP; Singh J; Lang RM; Zareba KM; Patel AR
    Eur Heart J Cardiovasc Imaging; 2023 May; 24(6):829-837. PubMed ID: 36624559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic Resonance in Transthyretin Cardiac Amyloidosis.
    Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Zumbo G; Knight DS; Kotecha T; Francis R; Hutt DF; Rezk T; Rosmini S; Quarta CC; Whelan CJ; Kellman P; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    J Am Coll Cardiol; 2017 Jul; 70(4):466-477. PubMed ID: 28728692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients.
    Yue X; Yang L; Wang R; Chan Q; Yang Y; Wu X; Ruan X; Zhang Z; Wei Y; Wang F
    Front Cardiovasc Med; 2022; 9():1017097. PubMed ID: 36330005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parametric mapping using cardiovascular magnetic resonance for the differentiation of light chain amyloidosis and transthyretin-related amyloidosis.
    Kravchenko D; Isaak A; Zimmer S; Öztürk C; Mesropyan N; Bischoff LM; Voigt M; Ginzburg D; Attenberger U; Pieper CC; Kuetting D; Luetkens JA
    Eur Heart J Cardiovasc Imaging; 2024 Sep; 25(10):1451-1461. PubMed ID: 38912832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing hypertensive cardiomyopathy from cardiac amyloidosis in hypertensive patients with heart failure: a CMR study with histological confirmation.
    Gil KE; Truong V; Liu C; Ibrahim DY; Mikrut K; Satoskar A; Varghese J; Kahwash R; Han Y
    Int J Cardiovasc Imaging; 2024 Dec; 40(12):2559-2570. PubMed ID: 39417970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac amyloidosis: in search of the ideal diagnostic tool.
    Mavrogeni SI; Vartela V; Ntalianis A; Vretou R; Ikonomidis I; Tselegkidou M; Paraskevaidis I; Markousis-Mavrogenis G; Noutsias M; Rigopoulos A; Kolovou G; Kastritis E
    Herz; 2021 Apr; 46(Suppl 1):9-14. PubMed ID: 31796976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of cardiac magnetic resonance imaging for the diagnosis of cardiac amyloidosis].
    Zhu KB; Cheng ZW; Tian Z; Zhao DC; Liu YT; Lin X; Chen TB; Xie HZ; Zeng Y; Fang LG; Jiang XC; Cui QC; Fang Q
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):915-9. PubMed ID: 22321275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Native T1 Mapping, Extracellular Volume Mapping, and Late Gadolinium Enhancement in Cardiac Amyloidosis: A Meta-Analysis.
    Pan JA; Kerwin MJ; Salerno M
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1299-1310. PubMed ID: 32498919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis.
    Ridouani F; Damy T; Tacher V; Derbel H; Legou F; Sifaoui I; Audureau E; Bodez D; Rahmouni A; Deux JF
    J Cardiovasc Magn Reson; 2018 Aug; 20(1):58. PubMed ID: 30115079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy.
    Vogelsberg H; Mahrholdt H; Deluigi CC; Yilmaz A; Kispert EM; Greulich S; Klingel K; Kandolf R; Sechtem U
    J Am Coll Cardiol; 2008 Mar; 51(10):1022-30. PubMed ID: 18325442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure.
    Yoshida A; Ishibashi-Ueda H; Yamada N; Kanzaki H; Hasegawa T; Takahama H; Amaki M; Asakura M; Kitakaze M
    Eur J Heart Fail; 2013 Feb; 15(2):166-75. PubMed ID: 23329703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis.
    Baggiano A; Boldrini M; Martinez-Naharro A; Kotecha T; Petrie A; Rezk T; Gritti M; Quarta C; Knight DS; Wechalekar AD; Lachmann HJ; Perlini S; Pontone G; Moon JC; Kellman P; Gillmore JD; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):69-80. PubMed ID: 31202744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and Prognostic Value of Non-late Gadolinium Enhancement Cardiac Magnetic Resonance Parameters in Cardiac Amyloidosis.
    Briasoulis A; Lama N; Rempakos A; Theodorakakou F; Stamatelopoulos K; Dimopoulos MA; Kelekis N; Kastritis E
    Curr Probl Cardiol; 2023 Apr; 48(4):101573. PubMed ID: 36586704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New-onset heart failure in infants: when the aetiological diagnosis becomes a challenge.
    Esmel-Vilomara R; Riaza L; Dolader P; Sabaté-Rotés A; Rosés-Noguer F; Gran F
    Eur J Pediatr; 2024 Jan; 183(1):493-498. PubMed ID: 37843615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
    Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of extracellular matrix expansion by CMR in infiltrative heart disease.
    Mongeon FP; Jerosch-Herold M; Coelho-Filho OR; Blankstein R; Falk RH; Kwong RY
    JACC Cardiovasc Imaging; 2012 Sep; 5(9):897-907. PubMed ID: 22974802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.
    Fontana M; Pica S; Reant P; Abdel-Gadir A; Treibel TA; Banypersad SM; Maestrini V; Barcella W; Rosmini S; Bulluck H; Sayed RH; Patel K; Mamhood S; Bucciarelli-Ducci C; Whelan CJ; Herrey AS; Lachmann HJ; Wechalekar AD; Manisty CH; Schelbert EB; Kellman P; Gillmore JD; Hawkins PN; Moon JC
    Circulation; 2015 Oct; 132(16):1570-9. PubMed ID: 26362631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.